Compare HLN & AMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | AMP |
|---|---|---|
| Founded | 2022 | 1894 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7B | 42.4B |
| IPO Year | N/A | 2008 |
| Metric | HLN | AMP |
|---|---|---|
| Price | $9.70 | $462.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | N/A | ★ $548.09 |
| AVG Volume (30 Days) | ★ 7.9M | 644.2K |
| Earning Date | 02-26-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.84% | 1.41% |
| EPS Growth | N/A | ★ 9.77 |
| EPS | N/A | ★ 36.28 |
| Revenue | N/A | ★ $18,911,000,000.00 |
| Revenue This Year | $6.77 | $2.28 |
| Revenue Next Year | $4.42 | $4.30 |
| P/E Ratio | $49.05 | ★ $12.54 |
| Revenue Growth | N/A | ★ 5.49 |
| 52 Week Low | $8.71 | $422.37 |
| 52 Week High | $11.42 | $550.18 |
| Indicator | HLN | AMP |
|---|---|---|
| Relative Strength Index (RSI) | 36.59 | 57.25 |
| Support Level | $9.60 | $447.58 |
| Resistance Level | $9.96 | $513.62 |
| Average True Range (ATR) | 0.13 | 11.55 |
| MACD | 0.01 | 3.98 |
| Stochastic Oscillator | 0.00 | 97.16 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With nearly $1.2 trillion in segment assets under management and advisory at year-end 2025, and with roughly 10,600 affiliated and employee advisors, Ameriprise is one of the larger US-based wealth managers. It also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $678 billion in assets under management at year-end 2025. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.69 trillion in assets under management and advisory across segments at year-end 2025.